The microtubule-targeted agent lisavanbulin (BAL101553) shows anti-tumor activity in lymphoma models.

Spriano, Filippo; Aresu, Luca; Cascione, Luciano; Risi, Giorgia; Arribas, Alberto J; Napoli, Sara; Forster-Gross, Nicole; Bachmann, Felix; Engelhardt, Marc; Lane, Heidi; Bertoni, Francesco

Spriano, Filippo; Aresu, Luca; Cascione, Luciano; Risi, Giorgia; Arribas, Alberto J; Napoli, Sara; Forster-Gross, Nicole; Bachmann, Felix; Engelhardt, Marc; Lane, Heidi; Bertoni, Francesco.

Afiliação

Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI Bellinzona, Switzerland.
Aresu L; Department of Veterinary Science, University of Turin Grugliasco, Turin, Italy.
Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI Bellinzona, Switzerland.
Risi G; SIB Swiss Institute of Bioinformatics Lausanne, Switzerland.
Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI Bellinzona, Switzerland.
Napoli S; Institute of Oncology Research, Faculty of Biomedical Sciences, USI Bellinzona, Switzerland.
Forster-Gross N; SIB Swiss Institute of Bioinformatics Lausanne, Switzerland.
Bachmann F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI Bellinzona, Switzerland.
Engelhardt M; Basilea Pharmaceutica International Ltd Allschwill, Switzerland.
Lane H; Basilea Pharmaceutica International Ltd Allschwill, Switzerland.
Bertoni F; Basilea Pharmaceutica International Ltd Allschwill, Switzerland.